Digital relapse prevention plan for substance use disorders: study protocol for a multicentre randomised controlled trial.
Rafael Salom, Álvaro Pico Rada, Juan Jesús Muñoz García...
https://pubmed.ncbi.nlm.nih.gov/41290251/Actively Recruiting
Led by Clínica Nuestra Señora de la Paz · Updated on 2026-05-14
150
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are evaluating a digital tool designed to monitor and detect early relapse in people undergoing addiction treatment for substance-related disorders. The study compares the traditional multidisciplinary treatment model with the same model enhanced by this technology. The goal is to demonstrate if the digital tool adds clinical value by improving long-term recovery outcomes. The treatments involve a standard comprehensive care model addressing biological, psychological, and social aspects of addiction through phases like assessment, detoxification, withdrawal management, rehabilitation, social reintegration, and follow-up. One group receives this standard care alone, while the other group receives the standard care plus a digital monitoring application that tracks clinical status, detects early relapse signs, and offers personalized interventions. Participants will be assessed using validated tools and biological tests such as urine toxicology and breath alcohol tests throughout intervention and follow-up over 12 months. Researchers will measure outcomes including withdrawal symptom reduction, craving decrease, emotional well-being, psychosocial functioning, relapse rates, and patient satisfaction. The study also evaluates the digital tools feasibility, acceptability, and clinical usefulness during therapeutic follow-up.
CONDITIONS
Prevention of Relapse in Behavioral Disorders
R
Rafael Salom Borrás, PhD
Á
Álvaro Pico Rada, Psychiatrist and Medical Direc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Clínica Nuestra Señora de la Paz
Lead Sponsor
Universidad Carlos III de Madrid
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 months
Participants receive a comprehensive multidisciplinary behavioral treatment including assessment, detoxification, withdrawal management, psychological and psychiatric therapy, rehabilitation, and social reintegration.
Regular visits throughout treatment duration
Duration - Up to 9 months
Participants continue behavioral treatment with or without a digital monitoring tool designed to detect early signs of relapse and provide personalized feedback during follow-up care.
Ongoing monitoring and support visits up to 12 months
Duration - Up to 12 months
Participants are monitored for relapse prevention and clinical progress with biological testing and psychological assessments conducted at baseline, post-treatment, and during follow-up visits to 12 months.
Visits at baseline, 3, 6, and 12 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Rafael Salom, Álvaro Pico Rada, Juan Jesús Muñoz García...
https://pubmed.ncbi.nlm.nih.gov/41290251/Clínica Nuestra Señora de la Paz
Lead Sponsor
Universidad Carlos III de Madrid
Collaborating Sponsor